Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NADH dehydrogenase subunit 4 (ND4), encoded by the mitochondrial genome, is a core subunit of Complex I (NADH:ubiquinone oxidoreductase) in the mitochondrial respiratory chain. It catalyzes electron transfer from NADH to ubiquinone and facilitates proton translocation across the inner mitochondrial membrane, contributing to ATP synthesis. Mutations in ND4 are linked to several diseases, including Leber Hereditary Optic Neuropathy (LHON) and mitochondrial myopathies, due to impaired ATP production.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NADH dehydrogenase subunit 4 (ND4).